Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
Clinical trial NCT00601159 · COMPLETED
Trial details
- NCT number
- NCT00601159
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-05-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.